Tenosynovial Giant Cell Tumor
3 competing products in clinical development for Tenosynovial Giant Cell Tumor.
Pipeline by Phase
Phase 21
Phase 31
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pexidartinib | Daiichi Sankyo | Phase 3 | Active | 44 |
| Pexidartinib | Daiichi Sankyo | Approved | Completed | 43 |
| Pexidartinib | Daiichi Sankyo | Phase 2 | Active | 39 |